Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Abivax SA Sponsored ADR (ABVX) vs Protagonist Therapeutics, Inc. (PTGX)

Abivax SA Sponsored ADR and Protagonist Therapeutics, Inc. are both Biotechnology companies. Abivax SA Sponsored ADR and Protagonist Therapeutics, Inc. are of similar size ($8.9B and $8.2B). Abivax SA Sponsored ADR has negative trailing earnings, so its P/E is not meaningful; Protagonist Therapeutics, Inc. trades at 117×. Protagonist Therapeutics, Inc. has the higher net margin (29.4% vs 0.00%) and the higher return on invested capital (61.8% vs 0.00%). Across the 14 metrics below, Protagonist Therapeutics, Inc. leads on 12 and Abivax SA Sponsored ADR on 2.

Valuation

Metric ABVX PTGX Biotechnology median
P/E n/m 116.99 7.88
P/S n/m 33.37 11.47
P/B 17.03 11.18 2.52
Price to free cash flow n/m 72.07 21.16
EV/EBITDA n/m 153.05 0.74
EV/Sales n/m 30.60 10.73
Earnings yield (6.66%) 0.85% (28.84%)
Free cash flow yield (3.12%) 1.39% (23.03%)

Profitability

Metric ABVX PTGX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 20.69% 0.00%
Net margin 0.00% 29.40% 0.00%
Free cash flow margin 0.00% 46.31% 0.00%
Return on equity (249.78%) 10.98% (57.72%)
Return on assets (137.67%) 10.34% (49.22%)
Return on invested capital 0.00% 61.84% 0.00%

Growth

Metric ABVX PTGX Biotechnology median
Revenue growth (TTM) — 34.81% 5.64%
EPS growth (last fiscal year) (80.20%) (148.46%) —
Revenue growth, 5-year CAGR — 9.96% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABVX PTGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.97 21.71 4.73
Net debt to EBITDA 2.19 3.49 0.96

Dividend

Metric ABVX PTGX Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric ABVX PTGX Biotechnology median
Market cap 8.23b 8.88b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack